KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Twist Bioscience (TWST) Invested Capital: 2018-2025

Historic Invested Capital for Twist Bioscience (TWST) over the last 7 years, with Sep 2025 value amounting to $473.0 million.

  • Twist Bioscience's Invested Capital rose 0.06% to $473.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $473.0 million, marking a year-over-year increase of 0.06%. This contributed to the annual value of $473.0 million for FY2025, which is 0.06% up from last year.
  • Per Twist Bioscience's latest filing, its Invested Capital stood at $473.0 million for Q3 2025, which was down 1.10% from $478.2 million recorded in Q2 2025.
  • In the past 5 years, Twist Bioscience's Invested Capital registered a high of $863.4 million during Q1 2022, and its lowest value of $440.1 million during Q1 2025.
  • For the 3-year period, Twist Bioscience's Invested Capital averaged around $540.6 million, with its median value being $491.1 million (2024).
  • As far as peak fluctuations go, Twist Bioscience's Invested Capital surged by 130.75% in 2021, and later fell by 25.31% in 2024.
  • Over the past 5 years, Twist Bioscience's Invested Capital (Quarterly) stood at $635.3 million in 2021, then increased by 17.48% to $746.3 million in 2022, then decreased by 20.94% to $590.0 million in 2023, then dropped by 22.73% to $455.9 million in 2024, then increased by 0.06% to $473.0 million in 2025.
  • Its Invested Capital stands at $473.0 million for Q3 2025, versus $478.2 million for Q2 2025 and $440.1 million for Q1 2025.